CN113679672A - 一种高水溶性阿莫西林可溶性粉的制备方法 - Google Patents
一种高水溶性阿莫西林可溶性粉的制备方法 Download PDFInfo
- Publication number
- CN113679672A CN113679672A CN202111089691.3A CN202111089691A CN113679672A CN 113679672 A CN113679672 A CN 113679672A CN 202111089691 A CN202111089691 A CN 202111089691A CN 113679672 A CN113679672 A CN 113679672A
- Authority
- CN
- China
- Prior art keywords
- amoxicillin
- powder
- soluble powder
- preparation
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 title claims abstract description 97
- 229960003022 amoxicillin Drugs 0.000 title claims abstract description 88
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 title claims abstract description 88
- 239000000843 powder Substances 0.000 title claims abstract description 66
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000002994 raw material Substances 0.000 claims abstract description 19
- 239000006184 cosolvent Substances 0.000 claims abstract description 14
- 238000002844 melting Methods 0.000 claims abstract description 12
- 230000008018 melting Effects 0.000 claims abstract description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 4
- 239000011248 coating agent Substances 0.000 claims abstract description 4
- 238000000576 coating method Methods 0.000 claims abstract description 4
- 239000008103 glucose Substances 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims abstract description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 39
- 229960001031 glucose Drugs 0.000 claims description 39
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 20
- 238000001035 drying Methods 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 10
- 229960004920 amoxicillin trihydrate Drugs 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 8
- 238000007873 sieving Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 230000005587 bubbling Effects 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- 238000001291 vacuum drying Methods 0.000 claims description 4
- 230000001502 supplementing effect Effects 0.000 claims description 2
- 230000007774 longterm Effects 0.000 abstract description 8
- 239000003814 drug Substances 0.000 abstract description 6
- 230000008859 change Effects 0.000 description 12
- 239000003651 drinking water Substances 0.000 description 6
- 235000020188 drinking water Nutrition 0.000 description 6
- 239000000945 filler Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 235000013350 formula milk Nutrition 0.000 description 5
- 230000001133 acceleration Effects 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000013078 crystal Substances 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 235000020610 powder formula Nutrition 0.000 description 2
- 239000000273 veterinary drug Substances 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 1
- 108010087702 Penicillinase Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000007919 dispersible tablet Substances 0.000 description 1
- 239000013020 final formulation Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229950009506 penicillinase Drugs 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
有效成分 | 阿莫西林 | 11.50kg |
助溶剂 | 无水葡萄糖熔融粉 | 15.00kg |
填充剂 | 无水葡萄糖 | 73.50kg |
有效成分 | 阿莫西林 | 11.50kg |
助溶剂 | 无水碳酸钠 | 3.75kg |
填充剂 | 无水葡萄糖 | 84.75kg |
月份 | 1 | 2 | 3 | 4 | 5 | 6 |
阿莫西林纯品 | 10.16% | 10.11% | 10.07% | 9.99% | 9.94% | 9.83% |
标示含量占比 | 101.6% | 101.1% | 100.7% | 99.9% | 99.4% | 98.3% |
月份 | 1 | 2 | 3 | 4 | 5 | 6 |
阿莫西林纯品 | 9.98% | 9.68% | 9.45% | 9.25% | 8.91% | 8.84% |
标示含量占比 | 99.8% | 96.8% | 94.5% | 92.5% | 89.1% | 88.4% |
有效成分 | 阿莫西林 | 34.0kg |
助溶剂 | 无水葡萄糖熔融粉 | 45.0kg |
填充剂 | 无水葡萄糖 | 21.0kg |
有效成分 | 阿莫西林 | 34.00kg |
助溶剂 | 无水碳酸钠 | 11.25kg |
填充剂 | 无水葡萄糖 | 54.75kg |
月份 | 1 | 2 | 3 | 4 | 5 | 6 |
阿莫西林纯品 | 29.76% | 29.44% | 29.18% | 28.91% | 28.74% | 28.69% |
标示含量占比 | 99.2% | 98.1% | 97.3% | 96.4% | 95.8% | 95.6% |
月份 | 1 | 2 | 3 | 4 | 5 | 6 |
阿莫西林纯品 | 28.87% | 27.13% | 25.64% | 24.05% | 23.47% | 22.97% |
标示含量占比 | 96.2% | 90.4% | 85.5% | 80.2% | 78.2% | 76.6% |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111089691.3A CN113679672B (zh) | 2021-09-17 | 2021-09-17 | 一种高水溶性阿莫西林可溶性粉的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111089691.3A CN113679672B (zh) | 2021-09-17 | 2021-09-17 | 一种高水溶性阿莫西林可溶性粉的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113679672A true CN113679672A (zh) | 2021-11-23 |
CN113679672B CN113679672B (zh) | 2023-04-18 |
Family
ID=78586572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111089691.3A Active CN113679672B (zh) | 2021-09-17 | 2021-09-17 | 一种高水溶性阿莫西林可溶性粉的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113679672B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116637075A (zh) * | 2023-05-26 | 2023-08-25 | 河北威远药业有限公司 | 一种高水溶性阿莫西林粉剂及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5935603A (en) * | 1995-04-26 | 1999-08-10 | Virbac Sa | Water soluble powder form compositions and their applications thereof |
CN101601657A (zh) * | 2009-07-13 | 2009-12-16 | 上海恒丰强动物药业有限公司 | 一种阿莫西林可溶性粉及其制备方法 |
CN104800167A (zh) * | 2015-04-22 | 2015-07-29 | 河南牧翔动物药业有限公司 | 一种氟苯尼考可溶性粉及其制备方法 |
-
2021
- 2021-09-17 CN CN202111089691.3A patent/CN113679672B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5935603A (en) * | 1995-04-26 | 1999-08-10 | Virbac Sa | Water soluble powder form compositions and their applications thereof |
CN101601657A (zh) * | 2009-07-13 | 2009-12-16 | 上海恒丰强动物药业有限公司 | 一种阿莫西林可溶性粉及其制备方法 |
CN104800167A (zh) * | 2015-04-22 | 2015-07-29 | 河南牧翔动物药业有限公司 | 一种氟苯尼考可溶性粉及其制备方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116637075A (zh) * | 2023-05-26 | 2023-08-25 | 河北威远药业有限公司 | 一种高水溶性阿莫西林粉剂及其制备方法 |
CN116637075B (zh) * | 2023-05-26 | 2024-03-15 | 河北威远药业有限公司 | 一种高水溶性阿莫西林粉剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN113679672B (zh) | 2023-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106176617B (zh) | 阿莫西林可溶性粉及其制备方法 | |
BG62842B1 (bg) | Таблетки, съдържащи амоксицилин и клавулант, с полимернопокритие | |
CN102766148B (zh) | 一种头孢孟多酯钠化合物及其组合物 | |
CN101036654B (zh) | 稳定的头孢哌酮舒巴坦药物复方制剂 | |
CN113679672B (zh) | 一种高水溶性阿莫西林可溶性粉的制备方法 | |
CN105343028B (zh) | 一种诺氟沙星的药物组合物及其制备方法 | |
CN103989630A (zh) | 盐酸莫西沙星氯化钠注射液及其制备方法 | |
CN113893221A (zh) | 一种高水溶性泰万菌素预混剂 | |
CN102755325B (zh) | 一种头孢西丁钠药物组合物、其粉针剂及其制备方法 | |
CN102327270B (zh) | 一种β-内酰胺类复方抗生素组合物 | |
CN110037995B (zh) | 一种稳定的盐酸帕罗西汀片剂及其制备方法 | |
CN101822822A (zh) | 一种普兰林肽的药物组合物及其制备方法 | |
CN108272756B (zh) | 一种阿莫西林可溶性粉及其制备方法 | |
JP2016528261A (ja) | クロロゲン酸粉末注射剤及びその製造方法 | |
SI20411A (sl) | Vodotopni praški za peroralno raztopino in njihova uporaba | |
CN115554308A (zh) | 一种阿苯达唑伊维菌素预混剂及其制备方法 | |
CN111557897B (zh) | 一种含有硝呋太尔的药物组合物及其制备方法 | |
CN104434817A (zh) | 一种利拉鲁肽的注射用缓释微球制剂 | |
CN102335136A (zh) | 一种供注射用美罗培南药物组合物及其制备方法 | |
CN112089693A (zh) | 一种注射用青霉素类组合物及其制备方法 | |
CN112704671B (zh) | 一种阿莫西林克拉维酸钾胶囊及其制备方法 | |
CN105412019A (zh) | 一种恩诺沙星可溶性粉及其制备方法 | |
CN106420599B (zh) | 一种枸橼酸咖啡因注射液的制备方法 | |
CN116115571A (zh) | 高浓度阿莫西林可溶性粉剂及其制备方法 | |
CN114796128B (zh) | 一种延胡索酸泰妙菌素预混剂及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Preparation Method of High Water Soluble Amoxicillin Soluble Powder Effective date of registration: 20231030 Granted publication date: 20230418 Pledgee: Jiangxi Fengcheng Rural Commercial Bank Co.,Ltd. Pledgor: JIANGXI INTEGRITY AND SUCCESS BIOTECHNOLOGY CO.,LTD. Registration number: Y2023980063410 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
CP01 | Change in the name or title of a patent holder |
Address after: 331199 No. 16, Huohuo Er Road, Fengcheng high tech Industrial Park, Yichun City, Jiangxi Province Patentee after: Jiangxi Chengbixin Biotechnology Co.,Ltd. Address before: 331199 No. 16, Huohuo Er Road, Fengcheng high tech Industrial Park, Yichun City, Jiangxi Province Patentee before: JIANGXI INTEGRITY AND SUCCESS BIOTECHNOLOGY CO.,LTD. |
|
CP01 | Change in the name or title of a patent holder |